Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path

被引:15
|
作者
Guaracha-Basanez, Guillermo A. [1 ]
Contreras-Yanez, Irazu [1 ]
Hernandez-Molina, Gabriela [1 ]
Estrada-Gonzalez, Viviana A. [1 ]
Pacheco-Santiago, Lexli D. [1 ]
Valverde-Hernandez, Salvador S. [1 ]
Galindo-Donaire, Jose Roberto [1 ]
Pelaez-Ballestas, Ingris [2 ]
Pascual-Ramos, Virginia [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran IN, Dept Immunol & Rheumatol, Mexico City, DF, Mexico
[2] Hosp Gen Mexico Dr Eduardo Liceaga, Rheumatol Unit, Mexico City, DF, Mexico
来源
PLOS ONE | 2022年 / 17卷 / 01期
关键词
SOCIAL DETERMINANTS; HEALTH-STATUS; ARTHRITIS; VALIDATION; DISABILITY; EMOTION; ANXIETY; MODEL;
D O I
10.1371/journal.pone.0262756
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Previous models that assess quality-of-Life (QoL) in patients with rheumatic diseases have a strong biomedical focus. We evaluated the impact of COVID-19 related-health care interruption (HCI) on the physical, psychological, social relationships and environment QoL-dimensions, and explored factors associated with QoL when patients were reincorporated to the outpatient clinic, and after six-month follow-up. Patients and methods Study phase-1 consisted of a COVID-19 survey administered from June 24th -October 31st 2020, to outpatients with rheumatic diseases who had face-to-face consultation at outpatient clinic reopening. Study phase-2 consisted of 3 consecutive assessments of patient's QoL (WHOQOL-BREF), disease activity/severity (RAPID-3), and psychological comorbidity/ trauma (DASS-21 and IES-R) to patients from phase-1 randomly selected. Sociodemographic, disease and treatment-related information, and comorbidities were obtained. Multiple linear regression analysis identified factors associated with the score assigned to each WHOQOL-BREF dimension. Results Patients included (670 for phase-1 and 276 for phase-2), had primarily SLE and RA (44.2% and 34.1%, respectively), and all the dimensions of their WHOQOL-BREF were affected. There were 145 patients (52.5%) who referred HCI, and they had significantly lower dimensions scores (but the environment dimension score). Psycho-emotional factors (primarily feeling confused, depression and anxiety), sociodemographic factors (age, COVID-1 9 negative economic impact, years of scholarship, HCI and having a job), and biomedical factors (RAPID-3 score and corticosteroid use) were associated with baseline QoL dimensions scores. Psycho-emotional factors showed the strongest magnitude on dimensions scores. Most consistent predictor of six-month follow-up QoL dimensions scores was each corresponding baseline dimension score, while social determinants (years of scholarship and having a job), emotional factors (feeling bored), and biomedical aspects (RAPID 3) had an additional impact. Conclusions HCI impacted the majority of patient's QoL dimensions. Psycho-emotional, sociodemographic and biomedical factors were consistently associated with QoL dimensions scores, and these consistently predicted the QoL trajectory.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic
    Khabbazi, Alireza
    Kavandi, Hadiseh
    Paribanaem, Roghayeh
    Khabbazi, Raha
    Malek Mahdavi, Aida
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (10)
  • [2] Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians
    Schreiber, Karen
    Sciascia, Savino
    Bruce, Ian N.
    Giles, Ian
    Cuadrado, Maria J.
    Cohen, Hannah
    Gordon, Caroline
    Isenberg, David
    Jacobsen, Soren
    Middeldorp, Saskia
    Mosca, Marta
    Pavord, Sue
    Radin, Massimo
    Roccatello, Dario
    Salmon, Jane
    Vinet, Evelyne
    Voss, Anne
    Watkins, Linda
    Hunt, Beverley J.
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (12): : E735 - E736
  • [3] THE ROUTINE HEALTH CARE OF PATIENTS WITH RHEUMATIC DISEASES DURING THE PANDEMIC OF COVID-19
    Mariem, S.
    Yasmine, M.
    Miladi, S.
    Fazaa, A.
    Souebni, L.
    Ouenniche, K.
    Kassab, S.
    Chekili, S.
    Ben Abdelghani, K.
    Laatar, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1368 - 1368
  • [4] Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
    Dougados, Maxime
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (06): : E395 - E396
  • [5] Quality of Life of Patients With Cancer During the COVID-19 Pandemic
    Baffert, Kim-Arthur
    Darbas, Tiffany
    Lebrun-Ly, Valerie
    Pestre-Munier, Julia
    Peyramaure, Clementine
    Descours, Clementine
    Mondoly, Melanie
    Latrouite, Simon
    Bignon, Elisa
    Nicouleau, Samantha
    Geyl, Sophie
    Leobon, Sophie
    Deluche, Elise
    [J]. IN VIVO, 2021, 35 (01): : 663 - 670
  • [6] IMPACT OF COVID-19 PANDEMIC IN ECUADORIAN PATIENTS WITH RHEUMATIC DISEASES
    Maldonado, Genessis
    Guerrero, Roberto
    Intriago, Maria
    Intriago, Belen
    Vera, Claudia
    Vargas, Sara
    Aroca, Emilio
    Gonzalez, Jose
    Moreno, Mario
    Rios, Carlos
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S14 - S14
  • [7] Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
    Antonelli, Alessandro
    Fallahi, Poupak
    Elia, Giusy
    Ragusa, Francesca
    Paparo, Sabrina Rosaria
    Mazzi, Valeria
    Raimondo, Vincenzo
    Ferrari, Silvia Martina
    Ferri, Clodoveo
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (10): : E675 - E676
  • [8] Experiences of Patients with Rheumatic Diseases in the US During the Early Months of the COVID-19 Pandemic
    Wipfler, Kristin
    Shaw, Yomei
    Simon, Teresa
    Cornish, Adam
    England, Bryant
    Ogdie, Alexis
    Katz, Patricia
    Michaud, Kaleb
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
    Adnine, Anass
    Soussan, Ilias
    Nadiri, Khawla
    Coulibaly, Siriman
    Berrada, Khadija
    Najdi, Adil
    Abourazzak, Fatima Ezzahra
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2021, 17 (03) : 318 - 326
  • [10] Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic
    Adnine, Anass
    Nadiri, Khawla
    Soussan, Ilias
    Coulibaly, Siriman
    Berrada, Khadija
    Najdi, Adil
    Abourazzak, Fatima E.
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2021, 17 (03) : 303 - 311